Abiopharma

Listing and Quotation:

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Chief Executive Officer, Mr Nicholas Chua

Financial Statements and Related Announcement: Half Yearly Results

Change - Change in Corporate Information: UPDATES ON SUBSIDIARY OF THE GROUP PURSUANT TO LISTING RULE 706A

Net Asset Value(s)

General Announcement: VOLUNTARY LIQUIDATON OF A SUBSIDIARY - BITUO ENVIRONMENTAL TECHNOLOGIES (TIANJIN) CO., LTD.

Financial Statements and Related Announcement: Half Yearly Results

Form 8.3

Change - Announcement of Appointment: Appointment of Chief Executive Officer

LyondellBasell announces quarterly dividend